UniProt ID | ITM2B_HUMAN | |
---|---|---|
UniProt AC | Q9Y287 | |
Protein Name | Integral membrane protein 2B | |
Gene Name | ITM2B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 266 | |
Subcellular Localization |
Integral membrane protein 2B: Golgi apparatus membrane Single-pass type II membrane protein . Immature BRI2 (imBRI2) is cleaved by furin in the Golgi into mBRI2 and a Bri23 peptide. mBRI2 is transported to the plasma membrane and Bri23 peptide is s |
|
Protein Description | Plays a regulatory role in the processing of the amyloid-beta A4 precursor protein (APP) and acts as an inhibitor of the amyloid-beta peptide aggregation and fibrils deposition. Plays a role in the induction of neurite outgrowth. Functions as a protease inhibitor by blocking access of secretases to APP cleavage sites.; Mature BRI2 (mBRI2) functions as a modulator of the amyloid-beta A4 precursor protein (APP) processing leading to a strong reduction in the secretion of secretase-processed amyloid-beta protein 40 and amyloid-beta protein 42.; Bri23 peptide prevents aggregation of APP amyloid-beta protein 42 into toxic oligomers.. | |
Protein Sequence | MVKVTFNSALAQKEAKKDEPKSGEEALIIPPDAVAVDCKDPDDVVPVGQRRAWCWCMCFGLAFMLAGVILGGAYLYKYFALQPDDVYYCGIKYIKDDVILNEPSADAPAALYQTIEENIKIFEEEEVEFISVPVPEFADSDPANIVHDFNKKLTAYLDLNLDKCYVIPLNTSIVMPPRNLLELLINIKAGTYLPQSYLIHEHMVITDRIENIDHLGFFIYRLCHDKETYKLQRRETIKGIQKREASNCFAIRHFENKFAVETLICS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Ubiquitination | -----MVKVTFNSAL -----CCEEEECHHH | 33.97 | - | |
3 | Ubiquitination | -----MVKVTFNSAL -----CCEEEECHHH | 33.97 | - | |
5 | Phosphorylation | ---MVKVTFNSALAQ ---CCEEEECHHHHH | 16.04 | 27050516 | |
8 | Phosphorylation | MVKVTFNSALAQKEA CCEEEECHHHHHHHH | 22.07 | 25159151 | |
13 | Ubiquitination | FNSALAQKEAKKDEP ECHHHHHHHHCCCCC | 54.77 | 21890473 | |
13 | Ubiquitination | FNSALAQKEAKKDEP ECHHHHHHHHCCCCC | 54.77 | 21890473 | |
13 | Ubiquitination | FNSALAQKEAKKDEP ECHHHHHHHHCCCCC | 54.77 | 21906983 | |
16 | Ubiquitination | ALAQKEAKKDEPKSG HHHHHHHCCCCCCCC | 62.95 | 21906983 | |
17 | Ubiquitination | LAQKEAKKDEPKSGE HHHHHHCCCCCCCCC | 74.50 | 21906983 | |
21 | Ubiquitination | EAKKDEPKSGEEALI HHCCCCCCCCCCCEE | 69.88 | - | |
38 | S-palmitoylation | PDAVAVDCKDPDDVV CCCEEECCCCHHHCC | 4.29 | 29575903 | |
39 | Ubiquitination | DAVAVDCKDPDDVVP CCEEECCCCHHHCCC | 68.76 | 21906983 | |
76 | Phosphorylation | ILGGAYLYKYFALQP HHHHHHHHHHHCCCC | 7.32 | - | |
78 (in isoform 2) | Phosphorylation | - | 4.78 | 20068231 | |
85 (in isoform 2) | Phosphorylation | - | 36.68 | 20068231 | |
86 (in isoform 2) | Phosphorylation | - | 4.84 | 20068231 | |
90 (in isoform 2) | Phosphorylation | - | 11.87 | 20068231 | |
91 (in isoform 2) | Phosphorylation | - | 2.46 | 20068231 | |
100 (in isoform 2) | Phosphorylation | - | 6.28 | 20068231 | |
104 | O-linked_Glycosylation | DVILNEPSADAPAAL CEECCCCCCCCCHHH | 32.38 | OGP | |
114 (in isoform 2) | Phosphorylation | - | 19.46 | 20068231 | |
114 | O-linked_Glycosylation | APAALYQTIEENIKI CCHHHHHHHHHHHCC | 19.46 | OGP | |
165 | Phosphorylation | DLNLDKCYVIPLNTS ECCCCCEEEEECCCC | 13.73 | - | |
170 | N-linked_Glycosylation | KCYVIPLNTSIVMPP CEEEEECCCCEECCC | 26.82 | 21752865 | |
191 | Phosphorylation | LINIKAGTYLPQSYL HHHCCCCCCCCHHHE | 27.09 | 22210691 | |
192 | Phosphorylation | INIKAGTYLPQSYLI HHCCCCCCCCHHHEE | 18.57 | 22210691 | |
206 | Phosphorylation | IHEHMVITDRIENID ECEEEEECCCCCCCC | 14.07 | 22210691 | |
228 | Phosphorylation | RLCHDKETYKLQRRE HHHCCHHHHHHHHHH | 31.53 | 23532336 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ITM2B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
170 | N | Glycosylation |
| 21752865 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ITM2B_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H01184 | Familial dementia, including: Familial British dementia (FBD); Familial Danish dementia (FDD) | |||||
OMIM Disease | ||||||
176500 | Cerebral amyloid angiopathy, ITM2B-related 1 (CAA-ITM2B1) | |||||
117300 | Cerebral amyloid angiopathy, ITM2B-related 2 (CAA-ITM2B2) | |||||
616079 | Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities (RDGCA) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycosylation of BRI2 on asparagine 170 is involved in itstrafficking to the cell surface but not in its processing by furin orADAM10."; Tsachaki M., Serlidaki D., Fetani A., Zarkou V., Rozani I., Ghiso J.,Efthimiopoulos S.; Glycobiology 21:1382-1388(2011). Cited for: CLEAVAGE BY ADAM10; FURIN AND SPPL2B, GLYCOSYLATION AT ASN-170,SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASN-170. |